LEVOFLOXACIN IN 5% DEXTROSE INJECTION
LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Approved
DIN Number
02314932
Drug Class
Human
Market Date
Dec 23, 2011
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02314932
AIG Number0131663001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01MA12 LEVOFLOXACIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification08:12.18
Health Canada Classification
ACTIVE INGREDIENTS (1)
LEVOFLOXACINActive
Strength: 5 MG / ML
Monograph: LEVOFLOXACIN